Your browser doesn't support javascript.
loading
A 48-Week, Multicenter, Open-Label, Observational Study Evaluating Oral Rivastigmine in Patients with Mild-to-Moderate Alzheimer's Disease in Taiwan.
Chang, Chiung-Chih; Peng, Giia-Sheun; Lai, Te-Jen; Li, Chien-Hsun; Liu, Ching-Kuan.
Affiliation
  • Chang CC; Department of Neurology, Cognition and Aging Center, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kao-hsiung, Taiwan.
  • Peng GS; Taipei Veterans General Hospital Hsinchu Branch, Hsinchu County, Taiwan.
  • Lai TJ; Institute of Medicine and Department of Psychiatry, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • Li CH; Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
  • Liu CK; Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. ckliu@kmu.edu.tw.
Adv Ther ; 36(6): 1455-1464, 2019 06.
Article in En | MEDLINE | ID: mdl-30953330
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Cholinesterase Inhibitors / Alzheimer Disease / Rivastigmine Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Adv Ther Journal subject: TERAPEUTICA Year: 2019 Type: Article Affiliation country: Taiwan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Cholinesterase Inhibitors / Alzheimer Disease / Rivastigmine Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Adv Ther Journal subject: TERAPEUTICA Year: 2019 Type: Article Affiliation country: Taiwan